Morepen Laboratories Ltd (MOREPENLAB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Morepen Laboratories Ltd (MOREPENLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3303
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Morepen Laboratories Ltd (Morepen Laboratories) is a manufacturer and supplier of active pharma ingredients and formulations. The company offers active pharma ingredients, formulation and homehealth solutions. It offers products in forms of tablets, capsules, liquids and powders. Morepen Laboratories’ product categories include intermediate, drug master files and branded prescription drugs. The company offers homehealth products such as blood glucose monitors, blood pressure monitors, nebulizers, weighing scales, vaporizers, pulse oximeters, adult diapers and quickchek pregnancy tests, among others. It operates through its research and development facilities, and factories in India and the US. Morepen Laboratories is headquartered in New Delhi, India.

Morepen Laboratories Ltd (MOREPENLAB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Morepen Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Morepen Lab Enters into Agreement with Vesale Pharma 11
Asset Transactions 12
Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 12
Acquisition 13
Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 13
Morepen Laboratories Ltd – Key Competitors 14
Morepen Laboratories Ltd – Key Employees 15
Morepen Laboratories Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Feb 08, 2017: Morepen labs reports yet another growth-filled quarter 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Morepen Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Morepen Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Morepen Lab Enters into Agreement with Vesale Pharma 11
Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 12
Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 13
Morepen Laboratories Ltd, Key Competitors 14
Morepen Laboratories Ltd, Key Employees 15
Morepen Laboratories Ltd, Other Locations 16
Morepen Laboratories Ltd, Subsidiaries 16

List of Figures
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Morepen Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Morepen Laboratories Ltd (MOREPENLAB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HCR ManorCare Inc:企業の戦略・SWOT・財務情報
    HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report Summary HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Comision Federal de Electricidad:電力:M&Aディール及び事業提携情報
    Summary Comision Federal de Electricidad (CFE) is a Mexican state owned power utility. It carries out the generation, transmission, distribution, supply and commercialization of electricity. The company generates electricity through various energy sources including thermal, hydro, coal-fired, wind, …
  • Banco Santander SA:企業のM&A・事業提携・投資動向
    Banco Santander SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Santander SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Calfrac Well Services Ltd. (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd. (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • General Biologicals Corp (4117)-医療機器分野:企業M&A・提携分析
    Summary General Biologicals Corp (GBC) is a medical device company that develops and manufactures diagnostics and pharmaceutical products. The company provides in-vitro diagnostic devices. It offers liver inspection tools such as test reagents and equipment. GBC’s products include real-time PCR kits …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Immunomedics Inc (IMMU)-医療機器分野:企業M&A・提携分析
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and automimmune disorders. The company’s portfolio of antibody-drug conjugates are aimed to sp …
  • Weifang Changan Steel Tower Stock Co Ltd:企業の戦略的SWOT分析
    Weifang Changan Steel Tower Stock Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Marfin Investment Group Holdings S.A.:企業のM&A・事業提携・投資動向
    Marfin Investment Group Holdings S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marfin Investment Group Holdings S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Globus Spirits Limited:企業の戦略・SWOT・財務情報
    Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report Summary Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務情報
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Menasha Corporation:企業の戦略・SWOT・財務分析
    Menasha Corporation - Strategy, SWOT and Corporate Finance Report Summary Menasha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Delegat’s Group Limited:企業の戦略・SWOT・財務情報
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Colt Group Ltd:企業の戦略的SWOT分析
    Colt Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Teijin Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabo …
  • Gamida Cell Ltd:企業のM&A・事業提携・投資動向
    Gamida Cell Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gamida Cell Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Korn/Ferry International:企業の戦略・SWOT・財務分析
    Korn/Ferry International - Strategy, SWOT and Corporate Finance Report Summary Korn/Ferry International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bio-Gate Ag (BIG1):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Gate AG (Bio-Gate) is a medical technology company that develops, manufactures and markets antimicrobial products based on unique silver technologies. Its product portfolio includes antimicrobial plasma coating and additives, among others. The company also provides services such as produ …
  • Anhui Water Resources Development Co Ltd (600502):企業の財務・戦略的SWOT分析
    Summary Anhui Water Resources Development Co Ltd (Anhui Water) is an investment holding company. The company operates in the business of construction, real estate development, and hydropower investment construction and operation. It operates as a general contractor of water conservancy projects, hou …
  • Syngene International Ltd (SYNGENE):企業の財務・戦略的SWOT分析
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and contract research and manufacturing organization. The organization offers research, development and manufacturing programs. It also provides discovery medicinal chemistry, small molecule development, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆